175 related articles for article (PubMed ID: 17697357)
21. IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma.
Garcia-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Histopathology; 2005 Jul; 47(1):82-9. PubMed ID: 15982327
[TBL] [Abstract][Full Text] [Related]
22. The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.
Medina V; Croci M; Crescenti E; Mohamad N; Sanchez-Jiménez F; Massari N; Nuñez M; Cricco G; Martin G; Bergoc R; Rivera E
Cancer Biol Ther; 2008 Jan; 7(1):28-35. PubMed ID: 17932461
[TBL] [Abstract][Full Text] [Related]
23. Influence of thyroid hormone receptors on breast cancer cell proliferation.
Conde I; Paniagua R; Zamora J; Blánquez MJ; Fraile B; Ruiz A; Arenas MI
Ann Oncol; 2006 Jan; 17(1):60-4. PubMed ID: 16282247
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies specific for the IL-18 receptor.
Vermot-Desroches C; Subiger O; Guenot F; Sergent E; Bonnin B; Wijdenes J
Cell Immunol; 2005; 236(1-2):101-4. PubMed ID: 16157318
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma-induced nitric oxide inhibits the proliferation of murine renal cell carcinoma cells.
Tate DJ; Patterson JR; Velasco-Gonzalez C; Carroll EN; Trinh J; Edwards D; Aiyar A; Finkel-Jimenez B; Zea AH
Int J Biol Sci; 2012; 8(8):1109-20. PubMed ID: 22991499
[TBL] [Abstract][Full Text] [Related]
26. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
27. Expression of PDGF receptors and ligand-induced migration of partially differentiated human monocyte-derived macrophages. Influence of IFN-gamma and TGF-beta.
Krettek A; Ostergren-Lundén G; Fager G; Rosmond C; Bondjers G; Lustig F
Atherosclerosis; 2001 Jun; 156(2):267-75. PubMed ID: 11395022
[TBL] [Abstract][Full Text] [Related]
28. Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.
Scully OJ; Yu Y; Salim A; Thike AA; Yip GW; Baeg GH; Tan PH; Matsumoto K; Bay BH
Exp Biol Med (Maywood); 2015 Jul; 240(7):846-53. PubMed ID: 25573962
[TBL] [Abstract][Full Text] [Related]
29. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
30. Signal transduction mechanism of a peptide mimetic of interferon-gamma.
Subramaniam PS; Flowers LO; Haider SM; Johnson HM
Biochemistry; 2004 May; 43(18):5445-54. PubMed ID: 15122910
[TBL] [Abstract][Full Text] [Related]
31. Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex.
Thiel DJ; le Du MH; Walter RL; D'Arcy A; Chène C; Fountoulakis M; Garotta G; Winkler FK; Ealick SE
Structure; 2000 Sep; 8(9):927-36. PubMed ID: 10986460
[TBL] [Abstract][Full Text] [Related]
32. Heat shock proteins and cell proliferation in human breast cancer biopsy samples.
Vargas-Roig LM; Fanelli MA; López LA; Gago FE; Tello O; Aznar JC; Ciocca DR
Cancer Detect Prev; 1997; 21(5):441-51. PubMed ID: 9307847
[TBL] [Abstract][Full Text] [Related]
33. Armc8 expression was elevated during atypia-to-carcinoma progression and associated with cancer development of breast carcinoma.
Fan C; Zhao Y; Mao X; Miao Y; Lin X; Jiang G; Zhang X; Han Q; Luan L; Wang E
Tumour Biol; 2014 Nov; 35(11):11337-43. PubMed ID: 25119601
[TBL] [Abstract][Full Text] [Related]
34. The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.
Nagao M; Nakajima Y; Kanehiro H; Hisanaga M; Aomatsu Y; Ko S; Tatekawa Y; Ikeda N; Kanokogi H; Urizono Y; Kobayashi T; Shibaji T; Kanamura T; Ogawa S; Nakano H
Hepatology; 2000 Sep; 32(3):491-500. PubMed ID: 10960440
[TBL] [Abstract][Full Text] [Related]
35. Expression of IFNγR2 mutated in a dileucine internalization motif reinstates IFNγ signaling and apoptosis in human T lymphocytes.
Boselli D; Ragimbeau J; Orlando L; Cappello P; Capello M; Ambrogio C; Chiarle R; Marsili G; Battistini A; Giovarelli M; Pellegrini S; Novelli F
Immunol Lett; 2010 Nov; 134(1):17-25. PubMed ID: 20709103
[TBL] [Abstract][Full Text] [Related]
36. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
duPre' SA; Redelman D; Hunter KW
Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
[TBL] [Abstract][Full Text] [Related]
37. [Tumor infiltrating regulatory T cells in human breast cancer and associated draining lymph nodes: an in-situ analysis].
Wang HY; Shi QF; Sun Y; He JJ; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):95-100. PubMed ID: 23710915
[TBL] [Abstract][Full Text] [Related]
38. S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.
Petersson S; Bylander A; Yhr M; Enerbäck C
BMC Cancer; 2007 Nov; 7():205. PubMed ID: 17986321
[TBL] [Abstract][Full Text] [Related]
39. Type III interferon induces apoptosis in human lung cancer cells.
Li W; Huang X; Liu Z; Wang Y; Zhang H; Tong H; Wu H; Lin S
Oncol Rep; 2012 Sep; 28(3):1117-25. PubMed ID: 22766785
[TBL] [Abstract][Full Text] [Related]
40. A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-gamma and meta-iodobenzylguanidine.
Höpfner M; Sutter AP; Huether A; Ahnert-Hilger G; Scherübl H
BMC Cancer; 2004 May; 4():23. PubMed ID: 15154969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
